Tao Zhao

Dr. Tao Zhao

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JYJianhang You
Jianhang You
QYQing Yu
Qing Yu
RCRonghui Chen
Ronghui Chen
JLJianlin Li
Jianlin Li
TZTao Zhao
Tao Zhao
ZLZhong Lu
Zhong Lu
Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer. Despite advances in treatment, the prognosis remains poor due to late diagnosis. Cuproptosis (driven by copper ion accumulation) and disulfidptosis (driven by disulfide bond accumulation) are novel forms of programmed cell death, closely linked to tumor initiation, progression, and resistance. However, the specific roles of these mechanisms in LUAD remain inadequately studied. This study integrated multi-omics data from TCGA and GEO databases to systematically evaluate the differential expression and prognostic significance of copper and disulfide-related genes (DCRGs), identify two DCRG molecular subtypes, and construct a DCRG scoring model based on four key genes. Multi-omics analysis results revealed that the DCRG score not only accurately predicts prognosis in LUAD patients but is also closely associated with immune cell infiltration patterns and EGFR inhibitor responses. RT-qPCR validated the high expression of FURIN and RHOV in LUAD cells, supporting their role as potential therapeutic targets. Further Mendelian randomization analysis confirmed the causal relationship between FURIN and LUAD development. These findings provide novel biomarkers for the prognosis evaluation of LUAD based on cuproptosis and disulfidptosis mechanisms and offer a theoretical basis for targeting FURIN in LUAD treatment.

23 August 2021 in Respiratory Research
Verified
Journal Article
Open access
PDF file
TZTao Zhao
Tao Zhao
YJYan Jie
Yan Jie
ZMZhang Mingru
Zhang Mingru
CGchangping Gu
changping Gu
YFYang Fan
Yang Fan
YWYuelan Wang
Yuelan Wang
Background: Ventilator-induced lung injury (VILI) is a common complication in the treatment of respiratory diseases with high morbidity and mortality. ETS-domain containing protein (Elk1) and Matrix metalloproteinase (MMP) 9 are involved in VILI, but the roles have not been fully elucidated. This study examined the mechanisms of the activation of MMP-9 and Elk1 regulating barrier function in VILI in vitro and in vivo. Methods: For the in vitro study, Mouse lung epithelial cells (MLE-12) were pre-treated with Elk1 siRNA or MMP-9 siRNA for 48 h prior to cyclic stretch at 20% for 4 h. For the in vivo study, C57BL/6 mice were pre-treated with Elk1 siRNA or MMP-9 siRNA for 72 h prior to 4 h of mechanical ventilation. The expressions of Elk1, MMP-9, Tissue inhibitor of metalloproteinase 1 (TIMP-1), E-cadherin, and occludin were measured by Western blotting. The intracellular distribution of E-cadherin and occludin was shown by immunofluorescence. The degree of pulmonary edema and lung injury were evaluated by Hematoxylin–eosin (HE) staining, lung injury scores, Wet/Dry (W/D) weight ratio, total cell counts, and Evans blue dye. Results: 20% cyclic stretch and high tidal volume increases the expressions of Elk1, MMP-9, and TIMP-1, increases the ratio of MMP-9/TIMP-1, decreases the E-cadherin and occludin level. Elk1 siRNA or MMP-9 siRNA reverses the degradations of E-cadherin, occludin, and the ratio of MMP-9/TIMP-1 caused by cyclic stretch. Elk1 siRNA decreases the MMP-9 level with or not 20% cyclic stretch and high tidal volume. Conclusions: The results demonstrate mechanical stretch damages the tight junctions and aggravates the permeability in VILI, Elk1 plays an important role in affecting the tight junctions and permeability by regulating the balance of MMP-9 and TIMP-1, thus indicating the therapeutic potential of Elk1 to treat VILI.

3 October 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
RCRonghui Chen
Ronghui Chen
JYJianhang You
Jianhang You
SWSuxia Weng
Suxia Weng
TZTao Zhao
Tao Zhao
Regulatory cell death exhibits distinctive advantages in cancer therapy. Among such mechanisms, disulfidptosis effectively inhibits tumor growth by inducing disulfide bond stress and subsequent rupture under particular conditions, thus demonstrating substantial potential for cancer treatment. Genes associated with disulfidptosis contribute to the survival and proliferation of various cancer cell types. They significantly impact the tumor microenvironment (TME) by modulating cancer’s metabolic reprogramming and antioxidant response, achieving anti-tumor effects. This review explores the recently identified regulatory cell death mechanism, disulfidptosis, through an examination of its mechanisms, the relationship between relevant genes and cancer, analyses of the TME, and the prospects of emerging therapeutics, offering fresh insights for disulfidptosis research in oncology.

14 February 2025 in Medicine
Verified
Journal Article
Open access
JLJianlin Mm Li
Jianlin Mm Li
JYJianhang You
Jianhang You
ZLZaipu Mm Li
Zaipu Mm Li
JZJing Mm Zang
Jing Mm Zang
LWLin Wu
Lin Wu
TZTao Zhao
Tao Zhao
Background: Parkinson’s disease (PD) is a common neurodegenerative disorder marked by motor impairments such as stiffness, involuntary shaking, and slowed movement. In addition, PD patients frequently experience nonmotor symptoms, especially depression. This study uses a mixed-methods scientometric analysis to review global research trends and advancements in PD and depression. This analysis is vital for clinicians, researchers, and policymakers, identifying knowledge gaps and directing future research efforts. Methods: We conducted a comprehensive literature review on PD and depression using the Web of Science database from 2004 to 2023, facilitated by CiteSpace 6.1.R6. Our analysis examined collaborations among authors, institutions, countries, and keywords, incorporating insights from RCTs and qualitative studies. We calculated effect sizes and confidence intervals with precision. Ethical approval was not required as the study used publicly available data without personal information. Results: Our analysis included 3048 research papers and 915 reviews, involving 17,927 authors and 12,466 institutions. The United States and the University of Toronto led in publications. Studies revealed significant effect sizes with narrow confidence intervals, particularly on the prevalence and impact of depression in PD patients. High-frequency keywords included “Parkinson’s disease,” “depression,” “quality of life,” “non-motor symptom,” and “dementia.” Visual mapping identified critical research nodes and future directions. Conclusion: Over the past 2 decades, research on the PD-depression link has accelerated. Our analysis highlights prevailing trends and critical areas, providing evidence-based recommendations for therapeutic strategies. This study offers valuable insights for clinicians and researchers, emphasizing future research priorities to improve patient outcomes.

7 June 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
JWJun Wu
Jun Wu
YWYuqian Wu
Yuqian Wu
YSYefeng Sun
Yefeng Sun
JYJianhang You
Jianhang You
WZWenjie Zhang
Wenjie Zhang
TZTao Zhao
Tao Zhao
Background Clear cell renal cell carcinoma (ccRCC) is the most prevalent and highly aggressive subtype of kidney cancer. Despite the progress in research, the roles of lactate metabolism and immune-related genes (LMRGs) in its prognosis and immune microenvironment remain unclear. Until now, no studies have explored the potential impact of LMRGs on the prognosis of ccRCC and their relationship with the tumor immune microenvironment. Methods Transcriptomic analysis was carried out using the TCGA and GEO databases. Non-negative matrix factorization (NMF) was used to subtype ccRCC samples. The Cox proportional hazards regression model and the LASSO algorithm were combined to screen the core genes related to prognosis. The Kaplan–Meier survival analysis was used to assess the relationship between these genes and patient survival. The CIBERSORT and ESTIMATE algorithms were used to analyze the level of immune infiltration. Results Using NMF analysis, ccRCC samples were classified into two subtypes. Kaplan–Meier survival analysis revealed that patients in Cluster 2 exhibited a better prognosis than those in Cluster 1. LASSO regression analysis identified five key genes—STAT2, PDGFRL, APLNR, PRKCQ, and THRB—which were subsequently used to construct a prognostic model. The survival rate in the high‐risk group was significantly lower than that in the low‐risk group. Immune microenvironment analysis demonstrated that the high‐risk group exhibited higher immune cell infiltration, while the low‐risk group was enriched for metabolism‐related pathways. Tumor mutation burden (TMB) analysis indicated that TMB synergized with the risk score. Finally, the prognostic value of these key genes was validated using the K–M database. Conclusion Lactate metabolism and immune-related genes are of great significance in the prognostic evaluation of ccRCC. The core genes screened based on these mechanisms have the potential value as biomarkers.

29 December 2025 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
HZHaikun Zhang
Haikun Zhang
JYJinxiang Yu
Jinxiang Yu
CCChengcheng Chen
Chengcheng Chen
LCLe Cao
Le Cao
PMPengcheng Ma
Pengcheng Ma
TZTao Zhao
Tao Zhao
Background: This case report described the entire process of a 72-year-old Chinese woman undergoing resection of a giant thyroid tumor. The novelty of this case report lies in its emphasis on the crucial role of anesthetic management for giant thyroid tumors, particularly in patients with concurrent cardiac comorbidities. Case presentation: We present a 72-year-old Chinese female with a giant thyroid tumor caused respiratory compromise due to tracheal compression, complicated by atrial septal defect. She required general anesthesia for tumor resection. A multidisciplinary team developed critical contingency strategies: (1) awake endotracheal intubation under direct laryngoscopy, (2) a remimazolam/sufentanil combination for procedural tolerance, (3) improved tracheal catheter preparation, and (4) surgical tracheostomy readiness. Anesthesia maintenance was achieved with sevoflurane, supplemented by sufentanil and remifentanil for multimodal analgesia and vecuronium/mivacurium neuromuscular blockade. Successful tumor resection achieved complete decompression, with no postoperative complications documented during 30-day follow-up. Conclusions: This case demonstrates that meticulous interdisciplinary communication and structured perioperative protocols form the cornerstone of safe anesthesia practice for patients with dual pathology of airway compromise and cardiac comorbidities, providing crucial insights for managing such complex clinical scenarios.